Relypsa (NASDAQ: RLYP) is up 5.7% in pre-open trade following speculative reports from the Daily Mail that AstraZeneca (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE